Splenic vein thrombosis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Splenic vein thrombosis}} {{CMG}} ; {{AE}} {{Vbe}} ==Overview== == Cost- effectiveness of therapy== ==References== {{reflist|2}}") |
(No difference)
|
Latest revision as of 16:08, 14 December 2017
Splenic vein thrombosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Splenic vein thrombosis cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Splenic vein thrombosis cost-effectiveness of therapy |
FDA on Splenic vein thrombosis cost-effectiveness of therapy |
CDC on Splenic vein thrombosis cost-effectiveness of therapy |
Splenic vein thrombosis cost-effectiveness of therapy in the news |
Blogs on Splenic vein thrombosis cost-effectiveness of therapy |
Risk calculators and risk factors for Splenic vein thrombosis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]